||Two New Analyses Add to Abacavir Cardiovascular Risk Debate|
Two studies presented at IAS 2009 found no association between abacavir and increased risk of heart attack or stroke, and underlined the importance of confounding risk factors. (From aidsmap.com)
IAS 2009 itself has officially ended, but our coverage has just begun!
More Top Stories:
- Nevirapine Sports Better Lipid Profile Than Atazanavir, Study Suggests
Patients taking nevirapine may have a lower risk of developing cardiovascular disease than those taking ritonavir-boosted atazanavir, according to a 569-patient study by European researchers. The study found that although nevirapine's efficacy was non-inferior to that of atazanavir, nevirapine appeared to have a more favorable lipid profile. (From kaisernetwork.org)
- New Measures of Cardiovascular Dysfunction in People With HIV Pose New Questions
Two studies have generated differing results regarding the use of new methods to detect changes in arteries that could give rise to cardiovascular disease. (From aidsmap.com)
- Improved Surveillance of Cervical Cancer Recommended in Populations With High HIV Prevalence
Cervical cancer prevention guidelines may need to be reviewed to address the particular needs of HIV-infected women, due to poorer outcomes of treatment for precancerous cervical changes, data from a South African study suggest. (From aidsmap.com)
- High-Risk HPV Infection Raises HIV Risk at Least Fourfold; HPV Vaccine Study Suggested
Infection with one or more of the cancer-causing subtypes of human papillomavirus (HPV) multiplied the risk of acquiring HIV among young men by 4.5-fold in a randomized controlled study of circumcision in South Africa. (From aidsmap.com)
- Research Finds Resurgence of TB, Diarrhea and Malnutrition in Zimbabwe Due to Hyperinflation and Economic Collapse
The economic crisis since 2000 in Zimbabwe has led to a rapid rise in tuberculosis (TB) cases and rising rates of malnutrition, reported Michael Silverman, M.D. However, he also noted that it appears HIV prevalence in pregnant women is decreasing in the country. (From aidsmap.com)
- HIV Infection Not Found to Be Associated With Drug-Resistant TB in Khayelitsha, South Africa
An extremely high prevalence of rifampicin-resistant tuberculosis (TB) -- 72 cases per 100,000 people per year -- has been found in a cross-sectional study of individuals with suspected TB conducted in Khayelitsha township, situated 40 km outside of Cape Town. (From aidsmap.com)
- Sustained Response to Interferon Improves Fibrosis in HIV/HCV-Coinfected Patients
HIV-infected people who achieve a sustained virological response to hepatitis C treatment using pegylated interferon plus ribavirin may experience regression of fibrosis and even cirrhosis, according to study findings. (From aidsmap.com)
- Anal Cancer in Men With HIV Much More Common in Post-HAART Era: Could HPV Vaccination Help?
The annual incidence of anal cancer among people with HIV has continued to increase in recent years and now stands at 128 cases per 100,000, said Nancy Crum-Cianflone of the U.S. Infectious Disease Clinical Research Program. This is nearly 100 times the rate in the general population. (From aidsmap.com)
- Hepatitis B Vaccine Scale-Up and Treatment of HIV/HBV Coinfection Present Challenges
Hepatitis B vaccine coverage has increased dramatically in recent years, but some regions still lag behind and collaboration with broader health programmes would aid scale-up, according to a symposium presentation on viral hepatitis. (From aidsmap.com)
- More Coming Soon!
Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.